Table 2.
Treatment effect and toxicities of neoadjuvant chemoradiotherapy in the 60 patients with unresectable colon cancer
| Characteristic | n |
|---|---|
| No of patients by surgery type | |
| Simple colectomy | 35 (58.3%) |
| MVR | 22 (36.7%) |
| Surgery abandoned | 3 (5.0%) |
| No of patients by resection grade* | |
| R0 | 49 (86.0%) |
| R1 | 3 (5.3%) |
| R2 | 5 (8.7%) |
| No of patients by pCR* | |
| Yes | 15 (26.3%) |
| No | 42 (73.7%) |
| No of patients by down T stage* | |
| Yes | 47 (82.5%) |
| No | 10 (17.5%) |
| No of patients by down N stage* | |
| Yes | 53 (93.0%) |
| No | 4 (7.0%) |
| No of patients by myelosuppression | |
| Grade 0–2 | 48 (80.0%) |
| Grade 3–4 | 12 (20.0%) |
| No of patients by mucositis/dermatitis | |
| Grade 0–2 | 58 (96.7%) |
| Grade 3–4 | 2 (3.3%) |
| No of patients by GI toxicities | |
| Grade 0–2 | 57 (95.0%) |
| Grade 3–4 | 3 (5.0%) |
| No of patients by postsurgical complications* | |
| Grade 0–2 | 53 (93.0%) |
| Grade 3–4 | 4 (7.0%) |
Note:
*
The proportion was calculated by dividing the number of the patients treated with surgery (N=57) by the number of the patients in a defined subgroup.
Abbreviations: MVR, multivisceral resection; pCR, pathologic complete response; GI, gastrointestinal.